The psychopharmacology of epilepsy

Handb Clin Neurol. 2019:165:207-227. doi: 10.1016/B978-0-444-64012-3.00012-5.

Abstract

Epilepsy affects 1% of the world's population and is defined as two or more unprovoked seizures. Psychiatric conditions (depression, psychosis, anxiety, and attention deficit hyperactivity disorder (ADHD)) may coexist and are linked to negative seizure outcomes and poorer quality of life. There is an increasing body of evidence to suggest a bidirectional relationship between epilepsy and psychiatric disorders, which may imply shared pathophysiologic mechanisms. Extensive research has examined neurobiologic and neuroanatomic substrates for this association revealing some interesting similarities. Psychiatric disorders in people with epilepsy often go underdiagnosed and undertreated, due to fears of exacerbating psychiatric symptoms or provoking seizures, which may cause delays in optimal management. This chapter covers psychiatric conditions in epilepsy largely focusing on depressive disorders and psychotic disorders. Anxiety and ADHD in association with epilepsy are also discussed. Epidemiology, pathophysiologic mechanisms, and pharmacotherapies used to treat epilepsy and psychiatric disorders are also covered.

Keywords: Antidepressants; Attention deficit hyperactivity disorder; Depression; Epilepsy; Psychosis.

Publication types

  • Review

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Antidepressive Agents / therapeutic use*
  • Anxiety / drug therapy
  • Anxiety / epidemiology
  • Anxiety / psychology
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / epidemiology
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Depression / drug therapy
  • Depression / epidemiology
  • Depression / psychology
  • Epilepsy / drug therapy*
  • Epilepsy / epidemiology
  • Epilepsy / psychology*
  • Humans
  • Psychopharmacology

Substances

  • Anticonvulsants
  • Antidepressive Agents